Sandhu Amanjot, Fast Sharla, Bonnar Kari, Baier Ronald John, Narvey Michael
Department of Neonatology, University of Manitoba , Winnipeg, Manitoba, Canada .
Breastfeed Med. 2017 Nov;12(9):570-573. doi: 10.1089/bfm.2017.0017. Epub 2017 Aug 4.
To describe the results of utilizing a human milk-based human milk fortifier (HMHMF) as rescue therapy to meet nutritional requirements in very low birth weight and preterm infants demonstrating feeding intolerance to bovine-based human milk fortifier (BHMF) in the Canadian Neonatal Intensive Care Unit (NICU) setting.
At two Level III NICUs in Winnipeg, MB, Canada, a rescue protocol was implemented to provide HMHMF for infants demonstrating intolerance to BHMF. To qualify for rescue, infants were required to experience two episodes of significant gastrointestinal (GI) symptoms associated with fortification with BHMF. A case series report was conducted retrospectively examining the success of rescue therapy, growth rates, protein, and calorie intakes before and after initiation of HMHMF in seven infants.
Seven infants (birth weight 723 ± 247 g, gestation 25.3 ± 3.4 weeks) were treated with rescue fortification with HMHMF. All infants were transitioned off parenteral nutrition (PN) without relapse of GI symptoms. Growth rate, protein, and calorie intakes improved with the use of HMHMF.
Very low birth weight and preterm infants with GI intolerance to BHMF were successfully rescued with use of HMHMF. Improvements in growth were achieved without need for supplementation with PN through achievement of sufficient enteral calorie and protein intakes.
描述在加拿大新生儿重症监护病房(NICU)环境中,使用基于人乳的人乳强化剂(HMHMF)作为挽救疗法,以满足极低出生体重和早产且对基于牛乳的人乳强化剂(BHMF)表现出喂养不耐受的婴儿的营养需求的结果。
在加拿大曼尼托巴省温尼伯市的两个三级NICU中,实施了一项挽救方案,为对BHMF不耐受的婴儿提供HMHMF。要符合挽救条件,婴儿需经历两次与BHMF强化相关的严重胃肠道(GI)症状发作。进行了一项病例系列报告,回顾性检查了7名婴儿在开始使用HMHMF之前和之后挽救疗法的成功率、生长速率、蛋白质和卡路里摄入量。
7名婴儿(出生体重723±247克,胎龄25.3±3.4周)接受了HMHMF挽救性强化治疗。所有婴儿均停用了肠外营养(PN),且胃肠道症状未复发。使用HMHMF后,生长速率、蛋白质和卡路里摄入量均有所改善。
对BHMF有胃肠道不耐受的极低出生体重和早产婴儿通过使用HMHMF成功得到挽救。通过实现足够的肠内卡路里和蛋白质摄入量,在无需补充PN的情况下实现了生长改善。